Non-incretin pathway
Amylin-receptor activity complements GLP-1 and GIP work rather than duplicating it.
Cagrilintide არის ამილინის გახანგრძლივებული ანალოგი, რომელიც კვლევებში GLP-1 პეპტიდების პარალელურად გამოიყენება.
Because the acylation chemistry that extends its half-life also complicates synthesis, batch-to-batch consistency is the main quality question with this peptide — and the main reason to insist on current analytical data.
Amylin-receptor activity complements GLP-1 and GIP work rather than duplicating it.
Acylation supports protocols with less frequent administration in animal models.
Each batch is released against HPLC purity and mass-spectrometry identity criteria.
Held locally so cold-chain exposure is measured in days, not weeks of customs transit.
Amylin is released alongside insulin and influences gastric emptying and satiety signalling through the calcitonin-receptor/RAMP complex. Native amylin aggregates readily, which historically limited its research utility; analogues such as Cagrilintide were engineered specifically to remain soluble and stable.
Much of the current interest lies in combining an amylin analogue with an incretin agonist. Groups running these designs commonly pair Cagrilintide with Tirzepatide or Retatrutide, which is why we keep all three in stock at the same time.
Store lyophilised material at 2–8 °C, protect from light and avoid agitation after reconstitution, since mechanical stress promotes aggregation in amylin-family peptides.
მეტი კითხვა? იხილეთ სრული FAQ
ცივი ჯაჭვის მიწოდება თბილისში, ბათუმსა და ქუთაისში 1–3 სამუშაო დღეში, პარტიის CoA-სთან ერთად.
დაგვიკავშირდით